Provided by Tiger Trade Technology Pte. Ltd.

SPYRE THERAPEUTICS INC

107.02
+0.53000.50%
Volume:299.34K
Turnover:31.80M
Market Cap:9.44B
PE:-53.24
High:107.64
Open:106.49
Low:105.00
Close:106.49
52wk High:110.18
52wk Low:14.51
Shares:88.17M
Float Shares:80.98M
Volume Ratio:0.82
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-1.9755
ROE:-22.98%
ROA:-19.81%
PB:9.88
PE(LYR):-54.17

Loading ...

Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Correspondence

Form CORRESP - Correspondence
Sep 14, 2024

Correspondence

Form CORRESP - Correspondence
Aug 08, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Correspondence

Form CORRESP - Correspondence
Apr 25, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]